Coherus Oncology, Inc. (CHRS)

1.13 -0.04 (-3.42%) USD  |  NASDAQ  |  Sep 25, 16:00
1.15 +0.02 (+1.77%) After-Hours: 19:59
More

Coherus Oncology Cash and Short Term Investments (Annual) : 172.12M for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for CHRS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2012. Start Trial.
Date Value
December 31, 2025 172.12M
December 31, 2024 125.99M
December 31, 2023 117.75M
December 31, 2022 191.68M
December 31, 2021 417.20M
December 31, 2020 541.16M
December 31, 2019 177.67M
Date Value
December 31, 2018 72.41M
December 31, 2017 126.97M
December 31, 2016 125.01M
December 31, 2015 158.29M
December 31, 2014 150.45M
December 31, 2013 39.60M
December 31, 2012 14.60M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Enanta Pharmaceuticals, Inc. 188.86M
ACADIA Pharmaceuticals, Inc. 819.69M
Alnylam Pharmaceuticals, Inc. 2.908B
Anika Therapeutics, Inc. 57.48M
Savara, Inc. 235.70M